Rasouli N, Guder Arslan E, Catarig AM, Houlind K, et al. Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type
2 Diabetes Characteristics: Insights From STRIDE, a Randomized,
Placebo-Controlled, Double-Blind Trial. Diabetes Care 2025 Jun 21:dc251082. doi: 10.2337/dc25-1082.
PMID: 40543068
|